Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters











Publication year range
1.
Behav Brain Res ; 403: 113132, 2021 04 09.
Article in English | MEDLINE | ID: mdl-33485873

ABSTRACT

Memory formation depends upon several parametric training conditions. Among them, trial number and inter-trial interval (ITI) are key factors to induce long-term retention. However, it is still unclear how individual training trials contribute to mechanisms underlying memory formation and stabilization. Contextual conditioning in Neohelice granulata has traditionally elicited associative long-term memory (LTM) after 15 spaced (ITI = 3 min) trials. Here, we show that LTM in crabs can be induced after only two training trials by increasing the ITI to 45 min (2t-LTM) and maintaining the same training duration as in traditional protocols. This newly observed LTM was preserved for at least 96 h, exhibiting protein synthesis dependence during consolidation and reconsolidation as well as context-specificity. Moreover, we demonstrate that 2t-LTM depends on inter-trial and post-training ERK activation showing a faster phosphorylation after the second trial compared to the first one. In summary, we present a new training protocol in crabs through a reduced number of trials showing associative features similar to traditional spaced training. This novel protocol allows for intra-training manipulation and the assessment of individual trial contribution to LTM formation.


Subject(s)
Behavior, Animal/physiology , Brachyura/physiology , Memory Consolidation/physiology , Memory, Long-Term/physiology , Mitogen-Activated Protein Kinase Kinases/metabolism , Practice, Psychological , Protein Kinase Inhibitors/pharmacology , Protein Synthesis Inhibitors/pharmacology , Animals , Cycloheximide/pharmacology , Dimethyl Sulfoxide/administration & dosage , Flavonoids/pharmacology , Male , Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors , Protein Kinase Inhibitors/administration & dosage , Protein Synthesis Inhibitors/administration & dosage
2.
Neurobiol Learn Mem ; 131: 18-25, 2016 05.
Article in English | MEDLINE | ID: mdl-26968655

ABSTRACT

Spermidine (SPD) is an endogenous aliphatic amine that modulates GluN2B-containing NMDA receptors and improves memory. Recent evidence suggests that systemic SPD improves the persistence of the long term memory of fear. However, the role of hippocampal polyamines and its binding sites in the persistence of fear memory is to be determined, as well as its putative underlying mechanisms. This study investigated whether the intrahippocampal (i.h.) infusion of spermidine or arcaine, modulators of polyamine binding site at GluN2B-containing NMDA receptors, alters the persistence of the memory of contextual fear conditioning task in rats. We also investigated whether protein synthesis and cAMP dependent protein kinase (PKA) play a role in SPD-induced improvement of the fear memory persistence. While 12h post-training infusion of spermidine facilitated, arcaine and the inhibitor of protein synthesis (anisomycin) impaired the memory of fear assessed 7days after training. The infusion of arcaine, anisomycin or a selective PKA inhibitor (H-89), at doses that have no effect on memory per se, prevented the SPD-induced improvement of memory persistence. H-89 prevented the stimulatory effect of SPD on phospho-PKA/total-PKA ratio. These results suggests that the improvement of fear memory persistence induced by spermidine involves GluN2B-containing NMDA receptors, PKA pathway and protein synthesis in rats.


Subject(s)
Cyclic AMP-Dependent Protein Kinases/metabolism , Fear/physiology , Hippocampus/drug effects , Memory, Long-Term/drug effects , Nootropic Agents/pharmacology , Polyamines/metabolism , Protein Kinase Inhibitors/pharmacology , Protein Synthesis Inhibitors/pharmacology , Spermidine/pharmacology , Animals , Anisomycin/administration & dosage , Anisomycin/pharmacology , Behavior, Animal/drug effects , Behavior, Animal/physiology , Biguanides/administration & dosage , Biguanides/pharmacology , Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors , Isoquinolines/administration & dosage , Isoquinolines/pharmacology , Male , Nootropic Agents/administration & dosage , Protein Kinase Inhibitors/administration & dosage , Protein Synthesis Inhibitors/administration & dosage , Rats , Rats, Wistar , Spermidine/administration & dosage , Sulfonamides/administration & dosage , Sulfonamides/pharmacology
3.
Neurobiol Learn Mem ; 126: 1-6, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26493441

ABSTRACT

The medial prefrontal cortex (mPFC) is known for its role in decision making and memory processing, including the participation in the formation of extinction memories. However, little is known regarding its contribution to aversive memory consolidation. Here we demonstrate that neural activity and protein synthesis are required in the dorsal mPFC for memory formation of a conditioned taste aversion (CTA) task and that this region is involved in the retrieval of recent and remote long-term CTA memory. In addition, both NMDA receptor and CaMKII activity in dorsal mPFC are needed for CTA memory consolidation, highlighting the complexity of mPFC functions.


Subject(s)
Memory Consolidation/physiology , Mental Recall/physiology , Prefrontal Cortex/physiology , Taste Perception/physiology , Animals , Benzylamines/administration & dosage , Calcium-Calmodulin-Dependent Protein Kinase Type 2/physiology , Conditioning, Psychological/drug effects , Conditioning, Psychological/physiology , Emetine/administration & dosage , GABA-A Receptor Agonists/administration & dosage , Male , Memory Consolidation/drug effects , Mental Recall/drug effects , Muscimol/administration & dosage , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Protein Synthesis Inhibitors/administration & dosage , Rats, Wistar , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Receptors, N-Methyl-D-Aspartate/physiology , Signal Transduction/drug effects , Sulfonamides/administration & dosage , Taste Perception/drug effects , Valine/administration & dosage , Valine/analogs & derivatives
4.
Proc Natl Acad Sci U S A ; 110(3): 1071-6, 2013 Jan 15.
Article in English | MEDLINE | ID: mdl-23277583

ABSTRACT

Extinction of contextual fear in rats is enhanced by exposure to a novel environment at 1-2 h before or 1 h after extinction training. This effect is antagonized by administration of protein synthesis inhibitors anisomycin and rapamycin into the hippocampus, but not into the amygdala, immediately after either novelty or extinction training, as well as by the gene expression blocker 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole administered after novelty training, but not after extinction training. Thus, this effect can be attributed to a mechanism similar to synaptic tagging, through which long-term potentiation can be enhanced by other long-term potentiations or by exposure to a novel environment in a protein synthesis-dependent fashion. Extinction learning produces a tag at the appropriate synapses, whereas novelty learning causes the synthesis of plasticity-related proteins that are captured by the tag, strengthening the synapses that generated this tag.


Subject(s)
Extinction, Psychological/physiology , Learning/physiology , Amygdala/drug effects , Amygdala/physiology , Animals , Anisomycin/administration & dosage , Dichlororibofuranosylbenzimidazole/pharmacology , Extinction, Psychological/drug effects , Fear/drug effects , Fear/physiology , Hippocampus/drug effects , Hippocampus/physiology , Learning/drug effects , Long-Term Potentiation/drug effects , Long-Term Potentiation/physiology , Male , Protein Synthesis Inhibitors/administration & dosage , Rats , Rats, Wistar , Sirolimus/administration & dosage , Transcription, Genetic/drug effects
5.
Epilepsia ; 53(7): 1225-32, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22642664

ABSTRACT

PURPOSE: Mossy fiber sprouting (MFS) is a frequent finding following status epilepticus (SE). The present study aimed to test the feasibility of using manganese-enhanced magnetic resonance imaging (MEMRI) to detect MFS in the chronic phase of the well-established pilocarpine (Pilo) rat model of temporal lobe epilepsy (TLE). METHODS: To modulate MFS, cycloheximide (CHX), a protein synthesis inhibitor, was coadministered with Pilo in a subgroup of animals. In vivo MEMRI was performed 3 months after induction of SE and compared to the neo-Timm histologic labeling of zinc mossy fiber terminals in the dentate gyrus (DG). KEY FINDINGS: Chronically epileptic rats displaying MFS as detected by neo-Timm histology had a hyperintense MEMRI signal in the DG, whereas chronically epileptic animals that did not display MFS had minimal MEMRI signal enhancement compared to nonepileptic control animals. A strong correlation (r = 0.81, p < 0.001) was found between MEMRI signal enhancement and MFS. SIGNIFICANCE: This study shows that MEMRI is an attractive noninvasive method for detection of mossy fiber sprouting in vivo and can be used as an evaluation tool in testing therapeutic approaches to manage chronic epilepsy.


Subject(s)
Epilepsy/pathology , Hippocampus/pathology , Magnetic Resonance Imaging , Manganese , Mossy Fibers, Hippocampal/drug effects , Animals , Anticonvulsants/pharmacology , Anticonvulsants/therapeutic use , Cycloheximide/administration & dosage , Disease Models, Animal , Drug Interactions , Epilepsy/chemically induced , Epilepsy/drug therapy , Hippocampus/drug effects , Image Processing, Computer-Assisted , Male , Mossy Fibers, Hippocampal/pathology , Muscarinic Agonists/toxicity , Pilocarpine/toxicity , Protein Synthesis Inhibitors/administration & dosage , Rats , Rats, Wistar , Statistics, Nonparametric , Thiopental/pharmacology , Thiopental/therapeutic use
6.
Neurobiol Learn Mem ; 92(1): 45-52, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19249379

ABSTRACT

Consolidation is the process by which a new memory is stabilized over time, and is dependent on de novo protein synthesis. A useful model for studying memory formation is gustatory memory, a type of memory in which a novel taste may become either safe by not being followed by negative consequences (attenuation of neophobia, AN), or aversive by being followed by post-digestive malaise (conditioned taste aversion, CTA). Here we evaluated the effects of the administration of a protein synthesis inhibitor in the nucleus accumbens (NAc) shell for either safe or aversive taste memory trace consolidation. To test the effects on CTA and AN of protein synthesis inhibition, anisomycin (100microg/microl) was bilaterally infused into the NAc shell of Wistar rats' brains. We found that post-trial protein synthesis blockade impaired the long-term safe taste memory. However, protein synthesis inhibition failed to disrupt the long-term memory of CTA. In addition, we infused anisomycin in the NAc shell after the pre-exposure to saccharin in a latent inhibition of aversive taste. We found that the protein synthesis inhibition impaired the consolidation of safe taste memory, allowing the aversive taste memory to form and consolidate. Our results suggest that protein synthesis is required in the NAc shell for consolidation of safe but not aversive taste memories, supporting the notion that consolidation of taste memory is processed in several brain regions in parallel, and implying that inhibitory interactions between both taste memory traces do occur.


Subject(s)
Anisomycin/administration & dosage , Feeding Behavior/drug effects , Memory/drug effects , Nucleus Accumbens/drug effects , Protein Synthesis Inhibitors/administration & dosage , Analysis of Variance , Animals , Avoidance Learning/drug effects , Catheterization , Conditioning, Classical/drug effects , Lithium Chloride/toxicity , Male , Rats , Rats, Wistar , Saccharin/administration & dosage , Sweetening Agents/administration & dosage , Taste
7.
Neurobiol Learn Mem ; 91(4): 466-72, 2009 May.
Article in English | MEDLINE | ID: mdl-19141326

ABSTRACT

Memory consolidation and reconsolidation require the induction of protein synthesis in some areas of the brain. Here, we show that infusion of the protein synthesis inhibitors anisomycin, emetine and cycloheximide in the entorhinal cortex immediately but not 180 min or 360 min after training in an object recognition learning task hinders long-term memory retention without affecting short-term memory or behavioral performance. Inhibition of protein synthesis in the entorhinal cortex after memory reactivation involving either a combination of familiar and novel objects or two familiar objects does not affect retention. Our data suggest that protein synthesis in the entorhinal cortex is necessary early after training for consolidation of object recognition memory. However, inhibition of protein synthesis in this cortical region after memory retrieval does not seem to affect the stability of the recognition trace.


Subject(s)
Entorhinal Cortex/physiology , Protein Synthesis Inhibitors/administration & dosage , Recognition, Psychology/physiology , Animals , Anisomycin/administration & dosage , Cycloheximide/administration & dosage , Emetine/administration & dosage , Entorhinal Cortex/drug effects , Male , Memory, Short-Term/physiology , Pattern Recognition, Physiological/physiology , Rats , Rats, Wistar , Recognition, Psychology/drug effects
8.
Neurobiol Learn Mem ; 89(3): 352-9, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18054256

ABSTRACT

Reconsolidation has proven to be a common phenomenon relevant to memory processing. However, the functional significance of this process is still a matter of debate. Previous work has shown that reconsolidation is indeed a process by which updated information is integrated, through the synthesis of proteins, to a memory trace. To further analyze the role that updated information plays in retrieved spatial memory susceptibility to disruption, we injected anisomycin bilaterally in the dorsal hippocampus of Wistar rats. Implanted animals were trained for 5 days on the Morris water maze (MWM) task and injected with anisomycin before the third or fifth training session. When memory was assessed a week later, only animals injected on the third training session showed disruption of long-term memory. Furthermore, when animals were trained for either 3 (middle-trained) or 5 (well-trained) days and a week later anisomycin was infused before a reminder session, only middle-trained rats infused with anisomycin showed reduced performance when tested for long-term memory. Finally, animals trained for 5 days and injected with anisomycin 7 days later on an extinction session showed impaired long-term extinction when tested. These results suggest that for spatial memory tasks acquisition of updated information is a necessary feature to undergo this process. We propose that reconsolidation is not an accurate term because it implies that consolidation happens again. This conception does not fit with the evidence; hence, we suggest that updating consolidation is a more descriptive term to refer to this process.


Subject(s)
Anisomycin/pharmacology , Hippocampus/drug effects , Memory/drug effects , Protein Synthesis Inhibitors/pharmacology , Amnesia/chemically induced , Animals , Anisomycin/administration & dosage , Extinction, Psychological/drug effects , Functional Laterality , Male , Maze Learning/drug effects , Protein Synthesis Inhibitors/administration & dosage , Rats , Rats, Wistar , Space Perception/drug effects
9.
Behav Brain Res ; 171(1): 162-9, 2006 Jul 15.
Article in English | MEDLINE | ID: mdl-16677727

ABSTRACT

Conditioned place preference is an animal model used to evaluate the affective properties of natural rewards and drugs of abuse. This animal model is a kind of classical conditioning that depends on learning and memory. The basolateral amygdala (BLA) plays an important role in the consolidation and extinction of memory for this task. However, there is a lack of evidence demonstrating protein synthesis dependent reconsolidation following retrieval in conditioned animals. In other words, is it possible to observe morphine-associated place preference if recall of this preference is disrupted? Accordingly, we investigated this hypothesis by BLA infusion of protein synthesis inhibitor, anisomycin, immediately after retrieval (test) in conditioned place preference paradigm. In the first experiment, the conditioned animals were exposed to the two sides of the apparatus for 15 min in a drug-free state during retrieval. In the second experiment, the animals received an injection of morphine (7.5 mg/kg, i.p.) and immediately after, they were exposed to the two sides of the apparatus for 15 min. Finally in the third experiment, after habituation and training in the conditioned place preference task, the animals received an injection of the unconditioned stimulus (morphine, i.p.; 7.5 mg/kg) followed by confinement for 10 min in the morphine-paired compartment (conditioned stimulus) during memory retrieval. For the three experiments the animals were subsequently exposed in a free-drug state to the two sides of the apparatus for the retest. Our results show that the protein synthesis inhibition in all of these experimental designs had no effect on conditioned place preference memory under conditions that would initiate reconsolidation, suggesting that if reconsolidation of a conditioned place preference task exists it is not mediated by protein synthesis in basolateral amygdala. The effect of anisomycin on consolidation of contextual fear conditioning was also investigated as a positive control to assure that the negative results were not due to methodological problems. Using the same dose of anisomycin (62.5 microg/1 microl) in morphine-associated place preference procedures, we have found that this anisomycin dose blocks the consolidation of contextual fear memory, ruling out the possibility that these negative results can be attributed to methodological problem of some sort.


Subject(s)
Amygdala/drug effects , Association Learning/drug effects , Conditioning, Classical/drug effects , Mental Recall/drug effects , Morphine/pharmacology , Protein Biosynthesis/physiology , Amygdala/metabolism , Analysis of Variance , Animals , Anisomycin/administration & dosage , Association Learning/physiology , Conditioning, Classical/physiology , Environment , Male , Mental Recall/physiology , Microinjections , Narcotics/pharmacology , Protein Biosynthesis/drug effects , Protein Synthesis Inhibitors/administration & dosage , Rats , Rats, Inbred WF , Reward
10.
Learn Mem ; 11(5): 572-8, 2004.
Article in English | MEDLINE | ID: mdl-15466311

ABSTRACT

It has been suggested that retrieval during a nonreinforced test induces reconsolidation instead of extinction of the mnemonic trace. Reconsolidation would preserve the original memory from the labilization induced by its nonreinforced recall through a hitherto uncharacterized mechanism requiring protein synthesis. Given the importance that such a process would have in terms of maintaining, as part of the animal behavioral repertoire, a learned response that has been devalued by experience, we analyzed its existence for the memory associated with a one-trial, step-down inhibitory avoidance task (IA), a memory whose consolidation and extinction require protein synthesis in the CA1 region of the dorsal hippocampus (CA1) and involve the participation of the basolateral amygdala (BLA) and entorhinal cortex (ENT). Rats were trained in IA, and 24 h later they were submitted either to a pure reactivation session (retrieval without stepping down), which was unable by itself to initiate extinction of the avoidance response, or to a second training session. Fifteen minutes before or 3 h after either the reactivation or the retraining sessions, animals were infused with the protein synthesis inhibitor anisomycin (ANI) into CA1, BLA, or ENT. Contrary to the prediction of the reconsolidation hypothesis, none of these treatments affected subsequent memory retention. Because reconsolidation is regarded to be a direct consequence of retrieval, one would expect that, when given before a retention test or a pure reactivation session, enhancers of memory expression should permanently improve retention and, therefore, facilitate retrieval both in that and in subsequent sessions. Using two well-known retrieval enhancers, noradrenaline and adrenocorticotropin(1-24), we could not find any evidence suggestive of reconsolidation. Hence, our results indicate that there is no retrieval-induced, protein synthesis-dependent process that would cause reconsolidation of IA memory.


Subject(s)
Avoidance Learning/physiology , Conditioning, Classical/physiology , Extinction, Psychological/physiology , Hippocampus/physiology , Memory/physiology , Animals , Anisomycin/administration & dosage , Avoidance Learning/drug effects , Conditioning, Classical/drug effects , Extinction, Psychological/drug effects , Hippocampus/drug effects , Inhibition, Psychological , Male , Memory/drug effects , Mental Recall/drug effects , Mental Recall/physiology , Microinjections , Neural Inhibition/drug effects , Neural Inhibition/physiology , Protein Biosynthesis/drug effects , Protein Synthesis Inhibitors/administration & dosage , Rats , Rats, Wistar
11.
Rev. gastroenterol. Méx ; Rev. gastroenterol. Méx;63(2): 66-71, abr.-jun. 1998. tab, ilus
Article in Spanish | LILACS | ID: lil-240892

ABSTRACT

Objetivo. Comparar la eficacia y tolerabilidad de una terapia triple contra una doble basadas en pantoprazol para erradicar Helicobacter pylori (H. pylori) en pacientes mexicanos con úlcera duodenal activa. Antecedentes. El tratamiento de la enfermedad ulcerosa péptica ha sido revolucionada con el hecho de que H. pylori generalmente induce grastritis crónica y se asocia con enfermedad ulcerosa péptica y la curación de la infección previene la recaída de la úlcera. Material y métodos. 74 pacientes H. pylori positivos con diagnóstico de úlcera duodenal activa recibieron ya sea pantoprazol 40 mg dos veces al día en combinación con claritromicina 500 mg tres veces al día en combinación con claritromicina 500 mg tres veces al día y amoxicilina 1 g dos veces al día (esquema triple = PAC) o bien pantoprazol en combinación con claritromicina y placebo (esquema doble = PC) durante 14 días. Con el fin de asegurar la completa cicatrización de la úlcera, todos los pacientes recibieron 2 semanas adicionales de pantoprazol 40 mg una vez al día. La prueba de aliento con urea marcada con 14C fue el criterio principal para determinar el índice de erradicación con < 150 desintegraciones por minuto (DPM) para considerar a un paciente erradicado. En todos los pacientes se realizaron cultivos y pruebas de susceptibilidad a antibioticos (E-test) así como estudio histológico. Resultados. En el análisis protocolo correcto (n=66) los índices de erradicación fueron: PAC 93.5 por ciento vs 54.3 por ciento (p<0.001); el 76 por ciento de cepas de H. pylori fueron resistentes al metronizadol. La tolerancia y apego al tratamiento fue excelente en ambos grupos. Conclusiones. La triple terapia (PAC) demostró ser superior a la doble (PC) para la erradicación de H. pylori en pacientes mexicanos con úlcera duodenal activa


Subject(s)
Humans , Male , Adolescent , Adult , Middle Aged , Amoxicillin/administration & dosage , Anti-Bacterial Agents/administration & dosage , Anti-Ulcer Agents/administration & dosage , Benzimidazoles/administration & dosage , Clarithromycin/administration & dosage , Data Interpretation, Statistical , Enzyme Inhibitors , Helicobacter Infections/diagnosis , Helicobacter Infections/drug therapy , Helicobacter pylori , Protein Synthesis Inhibitors/administration & dosage , Penicillins/administration & dosage , Placebos , Sulfoxides/administration & dosage , Duodenal Ulcer/diagnosis , Duodenal Ulcer/drug therapy
12.
Rev Gastroenterol Mex ; 63(2): 66-71, 1998.
Article in Spanish | MEDLINE | ID: mdl-10068730

ABSTRACT

OBJECTIVE: To compare the efficacy and tolerability of a triple vs dual pantoprazole based therapy to eradicate Helicobacter pylori (H. pylori) in mexican patients with florid duodenal ulcer. BACKGROUND: The treatment of peptic ulcer disease was revolutionized by the fact that H. pylori generally induces chronic gastritis and peptic ulcer disease and that the cure of the infection prevents ulcer relapses. MATERIAL AND METHODS: 74 H. pylori positive patients with florid duodenal ulcer were randomized to receive either pantoprazole 40 mg bid in combination with clarithromycin 500 mg tid and amoxicillin 1 g bid (triple regimen PAC) or pantoprazole in combination with clarithromycin and placebo (dual regimen PC) during 14 days. To ensure complete ulcer healing all patients received an additional 2 weeks treatment with pantoprazole 40 mg od. 14C Urea Breath test (UBT) was the main criteria used to determine eradication rate with < 150 disintegrations per minute (DPM) to consider a patient eradicated. In all patients culture, antibiotic susceptibility (E-test) and histology were performed. RESULTS: In the per protocol analysis (n = 66) the eradication rate was: PAC 93.5% vs PC 54.3% (p < 0.001). 76% of H. pylori strains were resistant to metronidazole. Tolerance and compliance were excellent in both groups. CONCLUSIONS: Triple therapy (PAC) was shown to be superior to dual therapy (PC) for H. pylori eradication in mexican patients with florid duodenal ulcer.


Subject(s)
Anti-Ulcer Agents/administration & dosage , Benzimidazoles/administration & dosage , Duodenal Ulcer/drug therapy , Enzyme Inhibitors/administration & dosage , Helicobacter Infections/drug therapy , Helicobacter pylori , Sulfoxides/administration & dosage , 2-Pyridinylmethylsulfinylbenzimidazoles , Adolescent , Adult , Amoxicillin/administration & dosage , Anti-Bacterial Agents/administration & dosage , Clarithromycin/administration & dosage , Data Interpretation, Statistical , Drug Administration Schedule , Drug Therapy, Combination , Duodenal Ulcer/diagnosis , Female , Helicobacter Infections/diagnosis , Humans , Male , Middle Aged , Omeprazole/analogs & derivatives , Pantoprazole , Penicillins/administration & dosage , Placebos , Protein Synthesis Inhibitors/administration & dosage
13.
Braz J Med Biol Res ; 29(4): 501-5, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8736115

ABSTRACT

Rats submitted to 2 h of restraint stress show reduced open arm exploration in the elevated plus maze 24 h later. To determine if this effect is dependent on protein synthesis during or after the restraint period, cycloheximide, a protein synthesis inhibitor, was injected into the right cerebral ventricle of male Wistar rats (200-250 g), immediately before (N = 19 animals per group), immediately after (N = 7 animals per group) or 2 h (N = 10 animals per group) following a 2-h period of forced restraint. Twenty-four hours later the animals were tested in the elevated plus maze. Non-stressed control groups received saline (SAL, N = 8-9 per group) or cycloheximide (CHX, N = 8-9 per group) and were tested 1 h or 24 h later in the maze. Pre- but not post-stress microinjections of cycloheximide (20 micrograms in 2 microliters) increased exploration in the elevated plus maze (% of time spent in open arms, pre-stress injection: SAL = 4.6 +/- 1.2, CHX = 10.7 +/- 2.3; number of enclosed arms entries: SAL = 3.6 +/- 0.5, CHX = 5.6 +/- 0.4). No drug effect was observed in non-stressed animals. These results suggest that blockade of protein synthesis during the restraint period may attenuate the behavioral consequences of stress.


Subject(s)
Cycloheximide/administration & dosage , Maze Learning/drug effects , Protein Synthesis Inhibitors/administration & dosage , Animals , Cycloheximide/pharmacology , Injections, Intraventricular , Male , Protein Synthesis Inhibitors/pharmacology , Rats , Rats, Wistar , Stress, Physiological/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL